犬關節炎治療市場規模、佔有率和成長分析（按關節炎類型、給藥途徑、治療方法、最終用戶和地區）- 產業預測（2025-2032）

2023 年全球犬關節炎治療市場規模為 27 億美元，預計將從 2024 年的 28.3 億美元成長到 2032 年的 41.2 億美元，預測期內（2025-2032 年）的複合年成長率為 4.8%。

全球犬關節炎治療市場正經歷強勁成長，這主要得益於骨關節炎盛行率的上升，尤其是在老化、肥胖和品種多樣化的犬類中。定期體檢和早期診斷的趨勢尤其明顯，尤其是在已開發地區，因為寵物飼主優先考慮獸醫護理，以提升寵物活動能力和控制疼痛。此外，對單株抗體、非類固醇消炎劑(NSAID) 和再生藥物等長期治療藥物的需求不斷成長，進一步推動了市場成長。遠端醫療服務和線上獸藥店的擴張也提高了市場滲透率。動物用藥品公司持續投入研發，市場前景更光明。總體而言，寵物醫療保健和預防性治療支出的增加，正在推動犬關節炎治療市場的良好成長。

目錄

介紹

• 分析目的
• 市場覆蓋
• 定義

分析方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與約束

執行摘要

• 市場概況與展望
• 供需趨勢分析
• 按細分市場進行機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場觀察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場魅力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術進步
• 案例研究

全球犬關節炎治療市場規模及複合年成長率（按關節炎類型分類）（2025-2032 年）

• 市場概覽
• 骨關節炎
• 骨軟骨病
• 類風濕性關節炎
• 創傷性關節炎

全球犬關節炎治療市場規模及依給藥途徑分類的複合年成長率（2025-2032）

• 市場概覽
• 口服
• 腸外
• 其他

全球犬關節炎治療市場規模及複合年成長率（按治療方法）（2025-2032 年）

• 市場概覽
• 非類固醇消炎劑（NSAID）
• 鴉片類藥物
• 幹細胞療法
• 同種異體幹細胞
• 自體幹細胞

全球犬關節炎治療市場規模及最終用戶複合年成長率（2025-2032）

• 市場概覽
• 醫院
• 專科診所
• 其他

全球犬關節炎治療市場規模及依通路分類的複合年成長率（2025-2032）

• 市場概覽
• 獸醫診所
• 零售藥局
• 網路藥局
• 其他

犬關節炎治療的全球市場規模和複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭格局

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要企業採取的策略
• 近期市場趨勢
• 主要企業市場佔有率（2024年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Boehringer Ingelheim
• Zoetis
• Elanco
• Decora Pharmaceuticals
• Merck Animal Health
• American Regent, Inc.
• Bayer AG
• Nutramax Laboratories Veterinary Sciences, Inc.
• VetStem, Inc.
• Virbac

結論和建議

Global Canine Arthritis Treatment Market size was valued at USD 2.7 billion in 2023 and is poised to grow from USD 2.83 billion in 2024 to USD 4.12 billion by 2032, growing at a CAGR of 4.8% during the forecast period (2025-2032).

The global canine arthritis treatment market is witnessing robust growth driven by the rising prevalence of osteoarthritis, particularly in aging, obese, and breed-prone dogs. Pet owners increasingly prioritize veterinary care for mobility and pain management, with a marked trend towards regular examinations and early diagnoses, especially in developed regions. This growth is further fueled by escalating demand for long-term therapeutics, including monoclonal antibodies, NSAIDs, and regenerative medicines. The expansion of telehealth services and online veterinary pharmacies is also enhancing market penetration. Consistent investments in research and development by veterinary pharmaceutical companies underline a positive market outlook. Overall, the increase in spending on pet healthcare and preventative treatments is propelling favorable growth in the canine arthritis treatment sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Canine Arthritis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Canine Arthritis Treatment Market Segments Analysis

Global Canine Arthritis Treatment Market is segmented by Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel and region. Based on Arthritis Type, the market is segmented into Osteoarthritis, Osteochondrosis, Rheumatoid arthritis and Traumatic arthritis. Based on Route of Administration, the market is segmented into Oral, Parenteral and Others. Based on Treatment, the market is segmented into Non-steroidal anti-inflammatory Medications (NSAIDs), Opioids, Stem Cell Therapy, Allogeneic Stem Cells and Autologous Stem Cells. Based on End-Users, the market is segmented into Hospitals, Speciality Clinics and Others. Based on Distribution Channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Pharmacies, Online Pharmacies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Canine Arthritis Treatment Market

The Global Canine Arthritis Treatment market is primarily driven by significant advancements in nutrition and veterinary medicine, which have enabled dogs to age more gracefully. As a result, there has been an increase in age-related diseases like arthritis, creating a heightened demand for wellness support and chronic care services specifically tailored for these conditions. This demographic shift highlights the growing focus on aging dogs, prompting substantial investments in treatments and medications aimed at promoting long-term joint health. Consequently, the market is evolving to meet the needs of pet owners seeking effective solutions for their canine companions suffering from arthritis.

Restraints in the Global Canine Arthritis Treatment Market

The Global Canine Arthritis Treatment market faces significant restraints due to the high costs associated with biologics and regenerative therapies, which restrict options for pet owners in low- and middle-income communities. This challenge is further exacerbated in rural areas, where there is often a shortage of veterinary specialists, making it difficult for pet owners to obtain timely diagnoses and management of these advanced therapies. These accessibility issues not only hinder the adoption of regenerative treatments but also impede the development of pet healthcare systems in emerging markets, ultimately affecting the overall growth potential of the market.

Market Trends of the Global Canine Arthritis Treatment Market

The Global Canine Arthritis Treatment market is witnessing a significant trend towards biologic and regenerative therapies, particularly monoclonal antibodies and stem cell treatments, which are leading the charge in innovative approaches. These therapies prioritize personalized care and sustainability, offering prolonged pain relief with minimal side effects, which resonates with both pet owners and veterinary professionals. This shift represents a strategic evolution in the market, emphasizing enhanced chronic care and the rapid advancement of veterinarian therapeutic solutions. As demand for more effective and less invasive treatments escalates, the market is evolving to meet these preferences, driving growth and innovation in canine arthritis management.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Case Studies

Global Canine Arthritis Treatment Market Size by Arthritis Type & CAGR (2025-2032)

• Market Overview
• Osteoarthritis
• Osteochondrosis
• Rheumatoid arthritis
• Traumatic arthritis

Global Canine Arthritis Treatment Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Oral
• Parenteral
• Others

Global Canine Arthritis Treatment Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Non-steroidal anti-inflammatory Medications (NSAIDs)
• Opioids
• Stem Cell Therapy
• Allogeneic Stem Cells
• Autologous Stem Cells

Global Canine Arthritis Treatment Market Size by End-Users & CAGR (2025-2032)

• Market Overview
• Hospitals
• Speciality Clinics
• Others

Global Canine Arthritis Treatment Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Veterinary Hospitals & Clinics
• Retail Pharmacies
• Online Pharmacies
• Others

Global Canine Arthritis Treatment Market Size & CAGR (2025-2032)

• North America (Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel)
  • US
  • Canada
• Europe (Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Boehringer Ingelheim
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Decora Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• American Regent, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nutramax Laboratories Veterinary Sciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VetStem, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations